The Econophy Group LLC

The Econophy™ Group's focus is biotech, particularly special situations, related to innovative technology diagnostics, that involve nuclear medicine and molecular imaging. Our global strategic partner relationships include pharma, life sciences, CROs, business development, commercialization, distribution, and capital markets. We prefer biotech ventures that have successfully completed their Phase I & II clinical trials with proven efficacy. Each target company is now positioned to enter its Phase III trial for FDA approval. Ideal candidates are those whose technology has clearly defined capability, scalability, adaptability, and versatility that will improve the patient care treatment process by reducing costs, and the patient treatment process time. Inclusively, the technology has proven itself to be safe, non-invasive, and far-reaching, as a solution provider.